The End of Human Papillomavirus Vaccine Exceptionalism

Acad Pediatr. 2018 Mar;18(2S):S17-S18. doi: 10.1016/j.acap.2017.04.022.

Author

Anne Schuchat¹

Affiliation

¹ Centers for Disease Control and Prevention, Atlanta, Ga. Electronic address: Aschuchat@cdc.gov.

PMID: 29502630
DOI: 10.1016/j.acap.2017.04.022

No abstract available

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Attitude of Health Personnel
Diphtheria-Tetanus-acellular Pertussis Vaccines / therapeutic use
Guideline Adherence
Humans
Meningococcal Vaccines / therapeutic use
Neoplasms / etiology
Neoplasms / prevention & control*
Papillomavirus Infections / complications
Papillomavirus Infections / prevention & control*
Papillomavirus Vaccines / therapeutic use*
Pediatrics*
Practice Guidelines as Topic
Vaccination Coverage*
Vaccines, Conjugate / therapeutic use

Substances

Diphtheria-Tetanus-acellular Pertussis Vaccines
MenACWY
Meningococcal Vaccines
Papillomavirus Vaccines
Vaccines, Conjugate